...
首页> 外文期刊>Radiation oncology >Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques
【24h】

Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques

机译:霍奇金淋巴瘤大靶标量的放疗:正向IMRT与常规技术相比具有正常的组织保留能力

获取原文

摘要

Background This paper analyses normal tissue sparing capability of radiation treatment techniques in Hodgkin's lymphoma with large treatment volume. Methods 10 patients with supradiaphragmatic Hodgkin's lymphoma and planning target volume (PTV) larger than 900 cm3 were evaluated. Two plans were simulated for each patient using 6 MV X-rays: a conventional multi-leaf (MLC) parallel-opposed (AP-PA) plan, and the same plan with additional MLC shaped segments (forward planned intensity modulated radiation therapy, FPIMRT). In order to compare plans, dose-volume histograms (DVHs) of PTV, lungs, heart, spinal cord, breast, and thyroid were analyzed. The Inhomogeneity Coefficient (IC), the PTV receiving 95% of the prescription dose (V95), the normal tissue complication probability (NTCP) and dose-volume parameters for the OARs were determined. Results the PTV coverage was improved (mean V95AP-PA = 95.9 and ICAP-PA = 0.4 vs. V95FPIMRT = 96.8 and ICFPIMRT = 0.31, p ≤ 0.05) by the FPIMRT technique compared to the conventional one. At the same time, NTCPs of lung, spinal cord and thyroid, and the volume of lung and thyroid receiving ≥ 30 Gy resulted significantly reduced when using the FPIMRT technique. Conclusions The FPIMRT technique can represent a very useful and, at the same time, simple method for improving PTV conformity while saving critical organs when large fields are needed as in Hodgkin's lymphoma.
机译:背景技术本文分析了放射治疗技术在治疗量大的霍奇金淋巴瘤中的正常组织保留能力。方法对10例radi舌上霍奇金淋巴瘤和计划目标体积(PTV)大于900 cm 3 的患者进行评估。使用6个MV X射线为每位患者模拟了两个计划:常规的多叶(MLC)平行对置(AP-PA)计划,以及具有其他MLC形片段的相同计划(向前计划强度调制放射治疗,FPIMRT )。为了比较计划,分析了PTV,肺,心脏,脊髓,乳房和甲状腺的剂量-体积直方图(DVH)。确定不均匀系数(IC),接受95%处方剂量的PTV(V95),正常组织并发症概率(NTCP)和OAR的剂量-体积参数。结果PTV覆盖率得到了改善(平均V95 AP-PA = 95.9和IC AP-PA = 0.4,而V95 FPIMRT = 96.8和IC与传统方法相比,FPIMRT技术的 FPIMRT = 0.31,p≤0.05)。同时,使用FPIMRT技术时,肺,脊髓和甲状腺的NTCP以及接受≥30 Gy的肺和甲状腺的体积显着减少。结论FPIMRT技术可以代表一种非常有用的方法,同时也是一种简单的方法,可以在需要大视野的情况下(如霍奇金淋巴瘤)改善PTV的一致性,同时节省关键器官。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号